Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen study
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1007/s00280-016-3067-x
dc.identifier.other
WOS:000379027200014
dc.description.volume
dc.description.issue
Publisher
SPRINGER
DOI
10.1007/s00280-016-3067-x